Investment
Features
FeesSafety
Academy
More
Pluang+

Moody's rates Sky Protocol B3, flags thin capital buffer under 1% of assets

Protocol Fundamentals
07 Oct 2026
Crypto Briefing
View Source
Neutral
Moody's rates Sky Protocol B3, flags thin capital buffer under 1% of assets

Moody's assigned a B3 credit rating with a stable outlook to Sky Protocol, formerly MakerDAO, marking the first stablecoin protocol rated by the agency. The rating reflects a speculative grade due to a thin capital buffer of about $90 million against roughly $10 billion in managed assets, under 1%. Sky's reserves have grown from $50 million to $92 million in 2026, with a target of $150 million to improve its equity cushion. S&P also rated Sky B-, making it the only stablecoin protocol rated by both agencies, which is significant for institutional investors requiring credit assessments before investing.

Sky Protocol's Moody's rating news is presented with Pluang's cryptocurrency market data for context. As of Oct 07, 2026 20:22 WIB, 6 of 50 major cryptocurrencies rose while 43 fell. EOS rose 8.13% to Rp12.649, AXS fell 8.01% to Rp21.180 with 89% buy order activity, and NEO fell 7.84% to Rp42.084 with 100% sell order activity.

More News

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

Hormel Foods price target cut to $23 amid hopes for valuation rebound despite 50% share drop.

BNP Paribas lowered Hormel Foods' price target from $26 to $23, indicating a potential 16.2% upside from its current price of around $19.80. Despite a 50.5% decline in its share price over five years, Hormel Foods remains attractive for dividend inve...

Analyst Insights
Neutral
56 minutes ago
Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays rates Becton Dickinson 'Underweight' amid $3B U.S. manufacturing partnership

Barclays initiated coverage of Becton, Dickinson and Company (BDX) with an "Underweight" rating, indicating a cautious outlook for the medical technology stock. BDX is partnering with the U.S. government to boost domestic manufacturing and strengthen...

Market News
Bearish
1 hour ago
Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley raises Eli Lilly price target to $1,430, signaling 20.8% potential upside.

Morgan Stanley increased its price target for Eli Lilly to $1,430 from $1,419, maintaining an Overweight rating. This new target implies a potential upside of about 20.8% from the current share price of around $1,184. The adjustment reflects updated ...

Analyst Insights
Bullish
1 hour ago
Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher sees 6% organic growth; analysts split on price targets amid mixed outlook.

Arthur J. Gallagher expects about 6% organic growth in Q3, driven by strong client retention and new business despite easing property insurance pricing. Cantor Fitzgerald lowered its price target to $280, below the $288 average from 19 analysts who m...

Analyst Insights
Bullish
2 hours ago
Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Zscaler's price target raised to $255 on strong AI-driven cybersecurity demand and growth outlook.

Needham raised Zscaler's price target to $255, citing strong demand for AI-related cybersecurity solutions. Zscaler aims to exceed $8 billion in annual recurring revenue by fiscal 2031, driven by increasing needs to protect against AI-powered cyberat...

Analyst Insights
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App